TNGX
Tango Therapeutics Inc
21.90$
-5.1%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.5% | -322.4% | – | -30.1% | +184.3% | -62.6% | -15.8% | +0.7% | +0.2% | +19.9% | -7.4% | -10.1% | +153.2% | -26.5% | -49.4% | +19.1% | +207.1% | -41.6% | -64.5% | +31.0% | -41.0% | +1,591.6% | -100.0% | – | – | – | |
| – | +2.8% | +16.6% | -96.7% | +4.4% | +3.6% | +4,645.2% | -97.4% | +16.1% | +2.4% | +77.8% | +19.0% | +0.4% | +3.4% | -59.4% | +0.7% | +1.3% | +1.1% | – | – | – | – | -11.2% | -13.7% | -3.3% | – | – | |
| – | – | – | – | -31.8% | +197.8% | -185.6% | – | -1.0% | -0.1% | +12.1% | -13.0% | -13.1% | +203.9% | -22.7% | -46.3% | +19.1% | +207.1% | -41.6% | -64.5% | +31.0% | -52.6% | +2,005.3% | -100.9% | – | – | – | |
| – | +2.8% | +16.6% | +16.1% | -0.4% | +27.2% | +14.9% | -1.3% | +12.5% | -2.4% | +21.1% | +1.2% | -3.6% | +2.3% | -5.3% | +15.4% | +21.5% | +1.5% | -13.9% | +2.0% | +7.4% | -11.7% | -4.2% | +8.0% | -0.6% | +12.5% | – | |
| – | +21.8% | +5.9% | +19.8% | +15.0% | +4.7% | +22.1% | +36.8% | +12.2% | +6.2% | +12.0% | -2.6% | +1.6% | +14.5% | +0.4% | -1.1% | +17.1% | +1.1% | +4.2% | -1.2% | +3.5% | -1.2% | -21.3% | +9.4% | +56.0% | +48.3% | – | |
| – | +21.8% | +5.9% | +601.0% | +2.1% | +23.5% | -80.1% | +511.8% | +12.3% | -0.6% | +17.6% | -0.3% | -2.6% | +5.0% | -1.6% | +13.1% | +20.5% | +1.4% | -10.0% | +1.2% | +6.4% | -9.2% | -8.7% | +4.1% | +16.7% | +23.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -397.5% | – | – | – | |
| – | – | – | – | – | – | – | +541.8% | -62.7% | +36.2% | +17.8% | +493.1% | -72.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -344.5% | – | – | – | |
| – | – | – | -100.0% | +1,078,617.2% | -128.4% | – | +185.5% | -196.6% | – | -29,200.0% | – | -4,566.7% | – | -64.1% | +104.3% | -14.9% | +62.5% | -16.9% | -9.3% | -30.6% | +2.9% | -128.6% | – | – | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -343.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -333.3% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.